The Sickle Cell Center Of The Commonwealth Of Penna - PA Philadelphia, Philadelphia 19106

The Sickle Cell Center Of The Commonwealth Of Penna entered the industry of Medical Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact by calling (215) 829-5391 during business hours. You can also write to the business’ Single Location at 700 Spruce St, Philadelphia, Pennsylvania PA 19106. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: The Sickle Cell Center Of The Commonwealth Of Penna
Place of Business: 700 Spruce St, Philadelphia, PA 19106
Contact Number: (215) 829-5391
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

The Sickle Cell Center Of The Commonwealth Of Penna is a company operating from Philadelphia, Pennsylvania providing professional Medical Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, The Sickle Cell Center Of The Commonwealth Of Penna has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative at (215) 829-5391 for related queries, or to locate its Single Location using the coordinates 39.945455,-75.153393.

The Single Location can also be found at the street address 700 Spruce St in Philadelphia, Pennsylvania 19106 and can be engaged online through the company website at , the company Twitter , and Facebook page .